The World Health Organisation has confirmed the discharge of three patients from an Ebola treatment centre in the Democratic Republic of Congo, marking a rare moment of hope in the midst of the country's latest and deadliest outbreak. The patients, two women and a man, were released from a facility in Beni, the North Kivu province town that has become the epicentre of the epidemic. They had tested negative for the virus after receiving experimental treatments.
The WHOs incident manager for the outbreak, Dr. Michael Ryan, described the recoveries as a testament to the resilience of the Congolese people and the effectiveness of early intervention. The patients received the experimental drug mAb114, a monoclonal antibody therapy developed by the US government, alongside supportive care. This is not a cure, but it improves survival rates significantly, Dr. Ryan said.
The Democratic Republic of Congo has been battling the Ebola outbreak since August 2018. It is the second deadliest in history, after the 2014-2016 West Africa epidemic that killed more than 11,000 people. The current outbreak has infected over 2,000 people and claimed more than 1,400 lives. The response has been complicated by conflict and community mistrust in the affected regions. Armed groups have attacked health workers and treatment centres, forcing aid organisations to suspend operations at times.
The recoveries come as health officials prepare to deploy a second experimental vaccine, produced by Johnson & Johnson, in a bid to contain the spread. The vaccine will be used alongside the existing Ebola vaccine, developed by Merck, which has been administered to over 200,000 people. The addition of a second vaccine could help protect more communities, particularly those in remote areas where access is limited.
Dr. Ryan warned, however, against complacency. The outbreak is not yet under control. New cases continue to emerge, and the risk of regional spread remains high. The WHOs latest situation report indicated 36 new confirmed cases in the week ending 26 May, a slight increase from the previous week. The majority of new infections are in the hotspots of Katwa and Mandima.
The recovery of these three patients is a small but significant victory in a long and difficult battle. It demonstrates that with the right resources and community engagement, this outbreak can be defeated. But the journey is far from over.
